SAN FRANCISCO, Aug. 21, 2024 (GLOBE NEWSWIRE) - ProLynx Inc. today announced the use of their technology to create a long-acting semaglutide that can be administered once monthly. The ProLynx technolo...
Partnerships underscore Tabnine's commitment to being the “the AI code assistant that you control,” while future-proofing AI Investments
TEL AVIV, Israel, Aug. 21, 2024 (GLOBE NEWSWIRE) - Tabnine,...
ROME, Aug. 21, 2024 (GLOBE NEWSWIRE) - In an interview with LaPresse on August 19th, Professor Celotto spoke about the pros and cons of the constitutional reform promoted by the Meloni government.
...
